FindTrial
Sign In

A Pharmaceutico-Analytical and Clinical study of Saubhagyadi Gutika on Pain during menstruation

A Pharmaceutico-Analytical and Clinical study of Saubhagyadi Gutika on Kashatartava w.s.r. to Dysmenorrhea - PACSK/KP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/032166
Enrollment
30
Registered
2021-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: Saubhagyadi Gautika: Dose-500mg twice a day for three consecutive menstrual cycles Intervention2: Saubhagyadi Gutika: Dose: Two Tab of Saubhagyadi Gutika (250mg each) BD before 7 days o

Sponsors

State Ayurvedic College and Hospital Lucknow
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who are suffering from primary dysmenorrheal. 2. Patient comes with chief complaint of pain during menses along with associated symptoms. 3. Patients within the age group 18-40 years. 4. Patients suffering for more than 3 consecutive cycles. 5. Patient with H/O using analgesics and other drug during menses.

Exclusion criteria

Exclusion criteria: 1.Patients below 18 and above 40 years of age. 2. Patients suffering from secondary dysmenorrhea; having organic pathology of uterus and adenexa. e.g.- Fibroid uterus, carcinoma of endometrium, venereal diseases ,PID, adenomyosis, endometriosis etc. 3. Patients suffering from systemic diseases. 4. Patient using intra uterine contraceptive devices. 5. Those under any hormonal therapy. 6. Patients having Pain abdomen associated with excessive bleeding p/v. 7. Patients with H/O thyroid dysfunction.

Design outcomes

Primary

MeasureTime frame
1.To assess the efficacy of Saubhagyadi Gutika 2.To assess the efficacy of trial drug on subjective parameter severity of pain,duration of pain,site of pain, nature of painTimepoint: Final assessment will be done after completion of trial of four consecutive menstrual cycles.—

Secondary

MeasureTime frame
To assess the efficacy of trial drug on associated symptoms Praseka (Nausea),Chhardi (Vomiting),Vibandha (Constipation) ,Atisara (Diarrhea),Aruchi (Loss of appetite),Shrama (Fatigue),Shirashula (Headache),Vankshana Shula (tenesmus of the bladder), Kati Shula, and Janu Shula,Swedadikya (excessive sweating),Tamodarshana (Faints)Timepoint: Follow up- each menstrual cycle during trial.—

Countries

India

Contacts

Public ContactDr Kanchan Pal

State ayurvedic college and hospital, Lucknow, Uttar Pradesh

goodluckramsagar@gmail.com9451586111

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026